Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.

@article{Davidson2021ScreeningFC,
  title={Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.},
  author={Karina W. Davidson and Michael J. Barry and Carol M. Mangione and Michael D. Cabana and Aaron B. Caughey and Esa M Davis and Katrina E. Donahue and Chyke A Doubeni and Alex H. Krist and Martha Y. Kubik and Li Li and Gbenga Ogedegbe and Douglas K. Owens and Lori Pbert and Michael Silverstein and James J. Stevermer and Chien-Wen Tseng and John B. Wong},
  journal={JAMA},
  year={2021},
  volume={325 19},
  pages={
          1965-1977
        }
}
Importance Colorectal cancer is the third leading cause of cancer death for both men and women, with an estimated 52 980 persons in the US projected to die of colorectal cancer in 2021. Colorectal cancer is most frequently diagnosed among persons aged 65 to 74 years. It is estimated that 10.5% of new colorectal cancer cases occur in persons younger than 50 years. Incidence of colorectal cancer (specifically adenocarcinoma) in adults aged 40 to 49 years has increased by almost 15% from 2000-2002… 

How Would You Screen This Patient for Colorectal Cancer?

The recommendation to begin CRC screening at age 45 is discussed, options for CRC screening are reviewed, and how to choose among the available options are discussed.

Age at Initiation of Lower Gastrointestinal Endoscopy and Colorectal Cancer Risk Among US Women.

In this cohort study, initiation of endoscopy before 50 years of age was associated with a reduced risk of CRC, including CRC diagnosed before 55 years ofAge, according to the American Cancer Society and the US Preventive Services Task Force.

Screening for Colorectal Cancer.

  • SamirK. Gupta
  • Medicine
    Hematology/oncology clinics of North America
  • 2022

Updates on age to start and stop colorectal cancer screening: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer.

This document is a focused update to the 2017 colorectal cancer screening recommendations from the U.S. Multi-Society Task Force on ColorectAL Cancer, and the decision to start or continue screening should be individualized and based on prior screening history, life expectancy, CRC risk, and personal preference.

Updates on Age to Start and Stop Colorectal Cancer Screening: Recommendations From the U.S. Multi-Society Task Force on Colorectal Cancer.

This document is a focused update to the 2017 colorectal cancer screening recommendations from the U.S. Multi-Society Task Force on ColorectAL Cancer, and the decision to start or continue screening should be individualized and based on prior screening history, life expectancy, CRC risk, and personal preference.

Colorectal cancer in the 45-to-50 age group in the United States: a National Cancer Database (NCDB) analysis

The objective was to audit the historic CRC case trends and impact of CRC in the 45-to-50-year-old category prior to new screening recommendations, and to ensure the most vulnerable segments benefit from the new guidelines.

US Cancer Screening Recommendations: Developments and the Impact of COVID-19

Rates of cancer screening, diagnosis, and treatment decreased significantly in the US and other developed nations during the height of the COVID-19 pandemic and lockdown and have since recovered, although not to baseline levels in many cases.

US women screen at lower rates for both cervical and colorectal cancers than a single cancer

Screening received by each woman shows a much lower rate of dual screening than prior single cancer screening rates, and addressing dual screening strategies rather than single cancer Screening programs for women 50-64 years may increase both cancer screenings rates.

Systematic Review of Colorectal Cancer Screening-Related Apps.

There are multiple free, publicly available apps that may encourage CRC screening uptake and despite their promise, there is a paucity of empirical evidence evaluating the efficacy and usability of these apps.

Sociodemographic correlates of colorectal cancer screening completion among women adherent to mammography screening guidelines by place of birth

Demographic and health service factors interact to influence colorectal cancer screening among women completing breast cancer screening, and interventions targeting specific underserved groups and financing reforms may enhance women’s colore CT screening rates.
...

References

SHOWING 1-10 OF 30 REFERENCES

Vital Signs: Colorectal Cancer Screening Test Use — United States, 2018

Concerted efforts are needed to inform persons aged <50 years about the benefit of screening so that screening can start at age 50 years, and among states, CRC screening prevalence was highest in Massachusetts and lowest in Wyoming.

Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force.

This microsimulation modeling analysis suggests that screening for colorectal cancer with stool tests, endoscopic tests, or computed tomography colonography starting at age 45 years provides an efficient balance of colonoscopy burden and life-years gained.

Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society

This guideline update used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence.

Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians

This American College of Physicians (ACP) guidance statement is to guide clinicians on age to start and stop CRC screening, frequency of screening, and optimal screening test in asymptomatic, average-risk adults, based on a critical review of existing guidelines and their evidence reviews.

Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

A systematic review of the effectiveness, test accuracy, and harms of screening for CRC to inform the US Preventive Services Task Force found there are several options to screen for colorectal cancer, each with a different level of evidence demonstrating its ability to reduce cancer mortality, its able to detect cancer or precursor lesions, and its risk of harms.

ACG Clinical Guidelines: Colorectal Cancer Screening 2021.

The purpose of this article is to update the 2009 American College of Gastroenterology CRC screening guidelines and provide recommendations on the role of aspirin for chemoprevention, quality indicators for colonoscopy, approaches to organized CRC screening and improving adherence to CRC screening.

Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years

The extensive experience of Medicare beneficiaries was used to estimate the effectiveness of screening colonoscopy in preventing CRC among elderly persons with no recent history of Colonoscopy, CRC, or adenomas.

Colorectal cancer statistics, 2017

Overall CRC incidence in individuals ages ≥50 years declined from 2009 to 2013 in every state except Arkansas, with the decrease exceeding 5% annually in 7 states; however, rectal tumor incidence in those ages 50 to 64 years was stable in most states.

Colorectal Cancer Incidence Patterns in the United States, 1974–2013

Age-specific CRC risk has escalated back to the level of those born circa 1890 for contemporary birth cohorts, underscoring the need for increased awareness among clinicians and the general public, as well as etiologic research to elucidate causes for the trend.